Information Density: ACIPHEX (Waylis Therapeutics / Woodward Pharma Services) – Signal Evidence & AI Readability

ACIPHEX (Waylis Therapeutics / Woodward Pharma Services)

(https://aciphex.com) 📸 Data Snapshot: May 26, 2026
Information Density — The Lens

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Info Density Power-words vs. Substance ratio.
24 Impact Weight: 30 / 100
80% Reputation

The site exhibits high information density for a commercial pharma page, featuring specific logistical data such as BIN # 610600, PCN# ASRx, and NPI # 1427160357. Heading fluff is minimal, with the majority of H2-H4 tags dedicated to mandatory safety disclosures and clinical indications. The body text provides specific pricing ($5.00 copay) and physical pharmacy addresses (Miramar, FL), though it leans on the repetitive value prop of brand-name vs. generic four times across the pages.

Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.

📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE · THIN (https://aciphex.com) Welcome to ACIPHEX® rabeprazole sodium tablet, delayed release – Aciphex®
[H2] Need Help Getting Your ACIPHEX® Prescription?
If you don’t currently have a prescription, our partners at ProCareRX can contact your doctor’s office on your behalf to assist in getting you an ACIPHEX® prescription. This is a free service for all patients. Get started by visiting ProCareRx to create your account.
[H2] Make Sure You Have Brand-Name ACIPHEX®
Look for the distinctive shape and marking of ACIPHEX®, so you get the brand-name medication you know.
[IMG: Aciphex tablets are yellow with]
504 chars
SUB-PAGE (https://aciphex.com/aciphex-copay-savings-program/) ACIPHEX® Copay Savings Program – Aciphex®
With the ACIPHEX® Copay Savings Card you may pay as little as $5.00 for your prescription*.
*Copay Savings Card only works on brand-name ACIPHEX®. Terms and conditions apply.
Waylis Therapeutics is a patient-first company, and we are continuously developing access and affordability programs to make sure that ACIPHEX® is easily accessible for those who need it.

[IMG: Aciphex logo]

[H4] ACIPHEX® Savings Program Information:
Show the information below to your pharmacist along with your valid commercial insurance information.
BIN #: 610600PCN#: ASRxGroup: 374ID#: 37401140253

[H2] Get Your Savings Card Today:
Please do not submit any personal information unless you have read and agree to the terms of our privacy policy. By clicking “submit” above, you agree that you have read, understand, and agree to these conditions.
[H2] Terms and Conditions
Offer valid for commercially insured patients who have a valid ACIPHEX® prescription. No substitutions permitted.
Not valid to individuals with Medicare Medicaid, TRICARE or any similar state or federal healthcare programs.
Benefit limited to one use per person for any 30-day period.
Valid only at participating pharmacies.
This offer is non-transferable, no substitutions are permissible, and offer may not be combined with any other coupon, discount, prescription savings card, free trial, or similar offer for specified prescription.
Federal law prohibits the selling, purchasing, trading, or counterfeiting of this Savings Card.
Offer only valid in the United States, Puerto Rico, or other selected U.S. Territories; this offer void in California, Massachusetts or where restricted or prohibited by law.
The value of the Program is intended exclusively for the benefit of the patient. The Program is not intended for the benefit of third parties, including without limitation third party payers, pharmacy benefit managers, or their agents.  Waylis will monitor program utilization data and reserves the right to discontinue or place monthly limits on co-pay assistance at any time if Waylis determines that the individual is subject to a plan that benefits third parties.
This offer is not conditioned on any past, present, or future purchase, including refills.
Waylis Therapeutics reserves the right to rescind, revoke or amend the program without notice.
Offer not applicable to co-pays of $5.00 or less.
Eligible patients may pay as little as $5.00 for their prescription.  By using this Savings Offer, eligible patients may receive a savings of up to $55.00 per fill off their co-pay or out-of-pocket costs.
2583 chars
SUB-PAGE (https://aciphex.com/aciphex-for-your-patients/) ACIPHEX® For Your Patients – Aciphex®
[H3] Commercial Insurance
E-Prescribing:
Find the NPI #: NPI 1427160357 in your e-prescribing system
Select ProCare Pharmacy Care as the Specialty Pharmacy*
2650 SW 145th Ave, Miramar, FL 33027-6606
*If the specialty pharmacy does not appear, please contact your e-prescribing provider to update your system
Save the Specialty Pharmacy in Your System
Transfer the Prescription
Copay Card Information
Commercially insured patients may pay as little as $5 for their prescription. Fill out the form below to receive your copay card information.

We care about your privacy: your email address is only used to send you your savings card information and is not saved here or anywhere else. For more information, visit the privacy policy page.
[H3] Medicare / Government Insurance OR No Insurance
Medicare / government insured patients and patients without insurance may qualify to get their prescription at a lower cost.
To get started, call the Waylis Patient Access and Affordability Program at: (888) 218-8897 or fill out this referral form and fax to (844) 470-1931
1066 chars
SUB-PAGE · THIN (https://aciphex.com/about-aciphex/) About ACIPHEX® – Aciphex®
ACIPHEX® (rabeprazole sodium) is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori (H. pylori) bacterial infections in the stomach.
294 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…
Explore the other reputation pillars for ACIPHEX (Waylis Therapeutics / Woodward Pharma Services)